We are building a successful company based on powerful breakthrough science. We believe our efforts hold the potential to end cancer.
We are determined to offer humanity a better life, free from cancer. While our goal is hugely ambitious, we are intensely driven to rid the planet of worry from cancer.
Calviri’s mission is to provide affordable products worldwide that will end suffering from cancer by combining a unique, highly immunogenic source of neoantigens with our peptide array platform. On our course to eradicate cancer we will develop new diagnostic and therapeutic products, and then preventative vaccines that will stop cancer from starting.
Subscribe to receive email updates on our latest news and events.
Marc WolffChief Executive Officer
Stephen Albert JohnstonFounding CEO, Chairman BOD
Kathryn Sykes PhDVP Research & Product Development
Terrence O’NeilDirector of Operations
Jacque Sokolov MDDirector
Jeffrey Le Benger MD FACSDirector
John Ballantyne PhDScientific Advisory Board Member
Steven W. Dow DVM PhDScientific Advisory Board Member
Peter P. Lee MDScientific Advisory Board Member
Terry A. McInnis MD MPH CPEScientific Advisory Board Member
At Calviri we are pushing hard to achieve a single goal: end suffering caused by cancer. Driven by our innovative science we are driving back the boundaries of the currently possible, to reimagine cancer detection, treatment and prevention.
Our ambition is huge, yet we are scientifically grounded. Calviri wants to end the outdated cancer treatment approach, and with it end not just deaths, but the misery of patients enduring terrible side effects. We want to create a better world, because we care, and because we can.
Calviri is at the center of cancer
- Early cancer detection
- Therapeutic vaccines
- Prophylactic vaccines
PBC – Phoenix Bioscience Core
850 North 5th Street
Phoenix, AZ 85004
Send us a message
Calviri is thankful to have the backing of experienced life sciences investors who see the potential we offer. If you are interested in being part of the future of cancer detection, treatment and prevention we’d like to hear from you.